Related Experiment Video
Updated: May 16, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through
Dan Wu1, Toshinori Ozaki, Yukari Yoshihara
1Laboratory of Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, 666-2 Nitona, Chiba 260-8717, Japan.
Abstract:
Representative tumor suppressor p53 plays a critical role in the regulation of proper DNA damage response. In this study, we have found for the first time that Runt-related transcription factor 1 (RUNX1) contributes to p53-dependent DNA damage response. Upon adriamycin (ADR) exposure, p53 as well as RUNX1 were strongly induced in p53-proficient HCT116 and U2OS cells, which were closely associated with significant transactivation of p53 target genes, such as p21(WAF)(1), BAX, NOXA, and PUMA. RUNX1 was exclusively expressed in the cell nucleus and formed a complex with p53 in response to ADR. Chromatin immunoprecipitation assay demonstrated that p53 together with RUNX1 are efficiently recruited onto p53 target gene promoters following ADR exposure, indicating that RUNX1 is involved in p53-mediated transcriptional regulation. Indeed, forced expression of RUNX1 stimulated the transcriptional activity of p53 in response to ADR. Consistent with these observations, knockdown of RUNX1 attenuated ADR-mediated induction of p53 target genes and suppressed ADR-dependent apoptosis. Furthermore, RUNX1 was associated with p300 histone acetyltransferase, and ADR-dependent acetylation of p53 at Lys-373/382 was markedly inhibited in RUNX1 knockdown cells. In addition, knockdown of RUNX1 resulted in a significant decrease in the amount of p53-p300 complex following ADR exposure. Taken together, our present results strongly suggest that RUNX1 is required for the stimulation of p53 in response to DNA damage and also provide novel insight into understanding the molecular mechanisms behind p53-dependent DNA damage response.
Insights
Runt-related transcription factor 1 (RUNX1) is crucial for the tumor suppressor p53
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- The tumor suppressor p53 is a key regulator of DNA damage response.
- The role of Runt-related transcription factor 1 (RUNX1) in DNA damage response is not well understood.
Purpose of the Study:
- To investigate the novel role of RUNX1 in p53-dependent DNA damage response.
- To elucidate the molecular mechanisms by which RUNX1 influences p53 activity.
Main Methods:
- Adriamycin (ADR) exposure in p53-proficient cells (HCT116, U2OS).
- Western blotting to detect p53 and RUNX1 induction.
- Chromatin immunoprecipitation (ChIP) assays to assess promoter recruitment.
- RUNX1 knockdown experiments using siRNA.
- Co-immunoprecipitation to study protein complex formation.
Main Results:
- RUNX1, like p53, is induced upon ADR exposure and localizes to the nucleus.
- RUNX1 forms a complex with p53 and is recruited to p53 target gene promoters.
- RUNX1 enhances p53 transcriptional activity, p53 target gene induction, and ADR-dependent apoptosis.
- RUNX1 facilitates p53 acetylation at Lys-373/382 by associating with p300 histone acetyltransferase.
Conclusions:
- RUNX1 is a novel co-factor required for p53 activation in response to DNA damage.
- RUNX1 promotes p53-mediated transactivation and apoptosis through physical and functional interaction with p53 and p300.
- This study provides new insights into the molecular mechanisms of p53-dependent DNA damage response.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair

